Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you miss your usual Mounjaro injection day, you can take it late — but only up to a point. The Mounjaro Patient Information Leaflet states that a missed dose can be taken within five days of your scheduled day; after that, skip it entirely and return to your normal weekly schedule. That five-day window is the limit; your prescriber and the NHS tirzepatide guidance are the right places to confirm this for your individual situation, since these are prescription-only medicines and any change to how you use them should be clinically led.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Your Mounjaro is prescribed for a specific weekly day, say, every Monday. If Monday passes and you remember on Tuesday, Wednesday, or even Friday morning, you are still inside the window. Go ahead and inject, then shift nothing: your next dose stays on the following Monday as usual. The five days run from your original scheduled day, not from when you remember.
Once day five has passed, the guidance is clear: do not take that dose at all. Skip it completely and wait for your next scheduled injection. The reason is straightforward, tirzepatide accumulates in the body and stacking a late dose too close to the next one raises the risk of side effects without adding meaningful benefit. If you are uncertain whether you are inside or outside the window on a particular occasion, call your prescriber or pharmacist rather than guessing.
A quick real-world note: a lot of people find they drift from their injection day after bank holidays, a fortnight abroad, or even a payday that disrupts the weekly routine. It happens. What matters is how you handle it when it does, and the five-day rule gives you a clear line.
For a detailed breakdown of what happens specifically on day two, our page on taking Mounjaro two days late covers that scenario in full.
Honestly, for most people, one day late is unremarkable. Tirzepatide has a half-life of roughly five days, meaning it stays active in your system well past your injection day. Missing by 24 hours will not undo your progress or spike side effects. What it will not do is give you a free pass to routinely shift your day, consistency matters for tolerability, for managing the appetite effects through the week, and for your prescriber's ability to review your treatment accurately.
If you find yourself regularly taking Mounjaro a day late because the original day no longer fits your life, the simple solution is to formally change your injection day. You can do this once, by choosing a new day at least seven days after your most recent dose, and then sticking to it. Talk to your prescriber before doing so; do not simply shift the day repeatedly on your own.
Our guide on how late you can take Mounjaro covers the full picture of the flexibility built into the dosing schedule and where the hard stops are.
Skip the missed dose without exception and take your next injection on your regular scheduled day. Do not double up. Do not take a half-dose. Do not take it the morning you remember if that morning is day six or beyond.
Returning to your schedule after a longer gap can occasionally feel like restarting, some people notice nausea resurfaces briefly, similar to when they first began treatment. This is because your body's adaptation to tirzepatide partly resets during a prolonged gap. The NHS medicines page for tirzepatide outlines what to expect and when to seek help if symptoms feel severe.
If you have missed several weeks rather than days (perhaps due to a supply issue or illness) contact your prescriber before resuming. They may recommend restarting at a lower dose to ease your system back in, rather than continuing from where you left off. For context on longer gaps and what changes if you are four days late, that page addresses the boundary cases in detail.
A single missed dose every few months is not a clinical concern in itself. A recurring pattern is different. Mounjaro is a prescription medicine dispensed as part of an ongoing treatment plan, and your prescriber makes decisions about dose increases and continued treatment based partly on how consistently you have been taking it. Gaps in your injection history matter to that picture.
At nume, a named prescriber reviews your case before every repeat order, not just at the start. That review is the right moment to raise any difficulties with timing, to ask about changing your injection day, or to flag that you have had a couple of gaps recently. It is a clinical conversation, not an exam, and it exists precisely so that your treatment reflects your actual situation.
If Mounjaro eligibility is something you are still working out, our BMI and Mounjaro eligibility page explains the licensed criteria. For an overview of the treatment itself, the Mounjaro treatment page covers how it works, what to expect, and how the process works at nume, sorry, at a UK-regulated pharmacy. And if cost is a consideration alongside timing, the context around Mounjaro pricing in the UK is worth reading before you decide where to get treatment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.